Adenoviridae Infections - 138 Studies Found

Completed : The Adv Halt Trial
: Adenovirus Disease
: 2010-11-12
: Drug: CMX001
  • Adults: 200mg
Completed : Administration of Virus-Specific Cytotoxic T-Lymphocytes
: Adenovirus Infection
: 2007-12-21
: Biological: CTL administration Adenovirus specific T cells
Completed : Injection of CD4 and CD8 + T Cells Anti-Cytomegalovirus (CMV) or Anti-adenovirus
:
  • Cytomegalovirus Infections
  • Adenovirus Infections

: 2011-03-28
: Other: Cell therapy Injection of specific T cell by intrav
Completed : A Placebo Controlled Comparison of Topical Zirgan Versus Genteal Gel for the Treatment of Adenovirus Conjunctivitis
:
  • Keratoconjunctivitis Due to Adenovirus
  • Viral Shedding
    • : 2012-01-31
    :
    • Drug: Zirgan 0.15% ganciclovir
Completed : Safety, Toxicity and MTD of One Intravenous IV Injection of Donor CTLs Specific for CMV and Adenovirus
:
  • Cytomegalovirus Infection
  • Adenovirus Infection

: 2009-04-13
: Biological: CMV/AdV specific T cells CTL Dose Given from Day +30 post SCT (stem cell transplant). For th
Completed : Using Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against Epstein Barr Virus, Adenovirus, And Cytomegalovirus
:
  • Epstein-Barr Virus Infections
  • Adenovirus
  • Biological: Ad5Ag85A Single in
Completed : Expanded Characterization of Immune Response to Merck Adenovirus 5 Gag/Pol/Nef Vaccine Given to HIV Uninfected Adults
: HIV Infections
: 2007-06-12
: Biological: MRKAd5 HIV-1 gag/pol/nef 1.5x10^10 Ad vg
Completed : Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL)
:
  • Adenovirus Infection
  • EBV Infection

: 2008-06-20
: Biological: Trivirus Specific CTLs for EBV, CMV and Adenovirus Infection
Not yet recruiting : Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of an Adenovirus-based Tuberculosis Vaccine Administered by Aerosol
: Tuberculosis
: 2014-12-19
: Biological: Ad5Ag85A
<<< Previous | Next >>>